AMILORIDE IN THE TREATMENT OF PRIMARY HYPERALDOSTERONISM AND ESSENTIAL HYPERTENSION

Amiloride (40 mg/day) was given to nineteen patients with primary hyperaldosteronism. There were significant falls in systolic and diastolic blood pressure, in total exchangeable sodium, and in serum sodium and bicarbonate; while total exchangeable potassium, total body potassium, serum potassium, chloride and urea, and plasma renin, angiotensin II and aldosterone all increased significantly. Amiloride was effective in reducing blood pressure in patients with and without adrenocortical adenoma. No carry‐over effect was seen on withdrawing amiloride. Similar changes were associated with amiloride treatment in five patients with essential hypertension; hyperkalaemia was not observed. Only negligible side‐effects were encountered in the entire series of twenty‐four patients.

[1]  A. Aakvaag,et al.  Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case. , 1974, The Journal of clinical endocrinology and metabolism.

[2]  J. Brown,et al.  The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess. , 1973, American heart journal.

[3]  R. Fraser,et al.  A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. , 1973, Clinical science and molecular medicine.

[4]  J. Brown,et al.  Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes. , 1973, Clinical science and molecular medicine. Supplement.

[5]  A. Linton,et al.  Protective effect of frusemide in acute tubular necrosis and acute renal failure. , 1973, Clinical science.

[6]  D. Davies,et al.  Amiloride in primary hyperaldosteronism with chronic peptic ulceration. , 1973, British medical journal.

[7]  D. Davies,et al.  Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na. , 1973, Metabolism: clinical and experimental.

[8]  J. Brown,et al.  Comparison of Surgery and Prolonged Spironolactone Therapy in Patients with Hypertension, Aldosterone Excess, and Low Plasma Renin , 1972, British medical journal.

[9]  A. Neville,et al.  Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin. , 1971, American heart journal.

[10]  J. A. Strong,et al.  Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. , 1971, Physics in medicine and biology.

[11]  G. Düsterdieck,et al.  Estimation of Angiotensin II Concentration in Human Plasma by Radioimmunoassay. Some Applications to Physiological and Clinical States , 1971, European journal of clinical investigation.

[12]  I. O'Muircheartaigh,et al.  Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. , 1970, Lancet.

[13]  G. Wilson,et al.  Clinical evaluation of amiloride, a potassium‐sparing diuretic , 1969, Clinical pharmacology and therapeutics.

[14]  J. Melby,et al.  Aldosteronism in hypertension. The spironolactone response test. , 1968, Annals of internal medicine.

[15]  J. Laragh,et al.  Amiloride: A Potassium‐Sparing Natriuretic Agent , 1968, Circulation.

[16]  J. Brown,et al.  Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone. , 1965, The Journal of endocrinology.

[17]  J. Brown,et al.  Plasma Renin in a Case of Conn's Syndrome with Fibrinoid Lesions: Use of Spironolactone in Treatment , 1964, British medical journal.

[18]  J. Brown,et al.  The estimation of renin in human plasma. , 1964, The Biochemical journal.

[19]  G. A. Rose,et al.  A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS. , 1964, Lancet.

[20]  W. Oelkers,et al.  Influence of spironolactone on endogenous steroid metabolism in man. , 1976, Clinical science and molecular medicine. Supplement.

[21]  J. Robertson,et al.  An international collaborative study of renin assay: establishment of the international reference preparation of human renin. , 1975, Clinical science and molecular medicine. Supplement.

[22]  K. Boddy.  A high sensitivity shadow-shield whole body monitor with scanning-bed and tilting chair geometries, incorporated in a mobile laboratory. , 1967, The British journal of radiology.